BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24522720)

  • 1. Prevalence of undiagnosed and inadequately treated type 2 diabetes mellitus, hypertension, and dyslipidemia in morbidly obese patients who present for bariatric surgery.
    Mostaedi R; Lackey DE; Adams SH; Dada SA; Hoda ZA; Ali MR
    Obes Surg; 2014 Jun; 24(6):927-35. PubMed ID: 24522720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A call to arms: obese men with more severe comorbid disease and underutilization of bariatric operations.
    Farinholt GN; Carr AD; Chang EJ; Ali MR
    Surg Endosc; 2013 Dec; 27(12):4556-63. PubMed ID: 23949482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of cardiovascular risk factors before and 6 and 12 months after bariatric surgery.
    Silva MA; Rivera IR; Barbosa EM; Crispim MA; Farias GC; Fontan AJ; Bezerra RA; Sá LG
    Rev Assoc Med Bras (1992); 2013; 59(4):381-6. PubMed ID: 23866938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of bariatric surgery in comparison with the control group on the prevention of comorbidities in people with severe obesity: a prospective cohort study.
    Ebadinejad A; Barzin M; Abiri B; Mahdavi M; Khalaj A; Ebrahimi D; Hosseinpanah F; Valizadeh M
    BMC Surg; 2022 Jul; 22(1):290. PubMed ID: 35902855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in Southwestern Ontario, Canada.
    Petrella RJ; Merikle E
    Clin Ther; 2008 Jun; 30(6):1145-54. PubMed ID: 18640470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed description of early response of metabolic syndrome after laparoscopic Roux-en-Y gastric bypass.
    Ali MR; Fuller WD; Rasmussen J
    Surg Obes Relat Dis; 2009; 5(3):346-51. PubMed ID: 19362060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypertension and dyslipidemia or their combination among US managed-care patients.
    Dutro MP; Gerthoffer TD; Peterson ED; Tang SS; Goldberg GA
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):684-91. PubMed ID: 17786069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Weight Loss and Metabolic Syndrome Remission after Bariatric Surgery: The Effect of Sex, Age, Metabolic Parameters and Surgical Technique - A 4-Year Follow-Up Study.
    Guerreiro V; Neves JS; Salazar D; Ferreira MJ; Oliveira SC; Souteiro P; Pedro J; Magalhães D; Varela A; Belo S; Freitas P; Carvalho D;
    Obes Facts; 2019; 12(6):639-652. PubMed ID: 31747662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Bariatric Surgery in Older Versus Younger Adolescents.
    Ogle SB; Dewberry LC; Jenkins TM; Inge TH; Kelsey M; Bruzoni M; Pratt JSA
    Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33526606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of rapid weight loss after bariatric surgery on the prevalence of arterial hypertension in severely obese patients with chronic kidney disease.
    Ortiz-Gomez C; Romero-Funes D; Gutierrez-Blanco D; Frieder JS; Fonseca-Mora M; Lo Menzo E; Szomstein S; Rosenthal RJ
    Surg Endosc; 2020 Jul; 34(7):3197-3203. PubMed ID: 31492989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, type 2 diabetes mellitus, and other comorbidities: a prospective cohort study of laparoscopic sleeve gastrectomy vs medical treatment.
    Leonetti F; Capoccia D; Coccia F; Casella G; Baglio G; Paradiso F; Abbatini F; Iossa A; Soricelli E; Basso N
    Arch Surg; 2012 Aug; 147(8):694-700. PubMed ID: 22508671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and the factors associated with microalbuminuria among patients with type 2 diabetes mellitus and/or hypertension in the urban areas of Puducherry district: a cross-sectional study.
    Sivanantham P; Sahoo JP; Lakshminarayanan S; Bobby Z; Loganathan V; Kar SS
    Fam Pract; 2024 Feb; 41(1):18-24. PubMed ID: 38180781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Comorbidity Treatment and Costs Associated With Bariatric Surgery Among Adults With Obesity in Canada.
    Davis JA; Saunders R
    JAMA Netw Open; 2020 Jan; 3(1):e1919545. PubMed ID: 31951277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is bariatric surgery effective for co-morbidity resolution in the super-obese patients?
    Hariri K; Guevara D; Dong M; Kini SU; Herron DM; Fernandez-Ranvier G
    Surg Obes Relat Dis; 2018 Sep; 14(9):1261-1268. PubMed ID: 30001889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nurse-led behavioral management of diabetes and hypertension in community practices: a randomized trial.
    Edelman D; Dolor RJ; Coffman CJ; Pereira KC; Granger BB; Lindquist JH; Neary AM; Harris AJ; Bosworth HB
    J Gen Intern Med; 2015 May; 30(5):626-33. PubMed ID: 25567758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of hypertension in relation with the normal albuminuria range in type 2 diabetes mellitus within the South Korean population: The Korean National Health and Nutrition Examination Survey, 2011-2012.
    Shin KE; Roh YK; Cho KH; Han KD; Park YG; Kim DH; Kim YH
    Prim Care Diabetes; 2017 Jun; 11(3):281-287. PubMed ID: 28363425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidly "Healthy" Obese Are Not Metabolically Healthy but Less Metabolically Imbalanced Than Those with Type 2 Diabetes or Dyslipidemia.
    Ferrer R; Pardina E; Rossell J; Oller L; Viñas A; Baena-Fustegueras JA; Lecube A; Vargas V; Balibrea JM; Caubet E; González O; Vilallonga R; Fort JM; Peinado-Onsurbe J
    Obes Surg; 2015 Aug; 25(8):1380-91. PubMed ID: 25515498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
    Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.